HealthQuill Department of Health and Human Services
The US regulator is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the market, a move that drew ire from dental experts.
Drugs Health Pharma

US plan to remove ingestible fluoride from children’s drugs draws ire

HQ Team May 14, 2025: The US regulator is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the.

Read More
The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took more than 15 months to address a February 2021 Abbott facility whistleblower complaint, according to a federal audit.
Drugs Health Pharma

US audit finds gaps in FDA’s procedures during infant formula crisis

The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took.

Read More
Research uncovers significant discrepancies in ingredient labels and presence of banned compounds
Drugs Health Pharma

US combats new high of animal sedative Tranq, fentanyl, heroin mix

HQ Team July 12, 2023: Xylazine hydrochloride, a sedative used in animals to provide relief from pain, is increasingly being found in the.

Read More